COHERUS BIOSCIENCES INC (CHRS)
US19249H1032 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | N/A | -291.80M | -287.10M | 132.20M | |||
| Depreciation Amortization | 5.33M | 3.79M | 3.70M | 3.50M | 2.90M | |||
| Change In Working Capital | 7.73M | -36.83M | -79.30M | 42.90M | -32.10M | |||
| Interest Paid | N/A | 37.86M | 34.90M | 18.70M | 17.00M | |||
| Taxes Paid | N/A | 118.00K | 0.00 | 1.20M | 4.00M | |||
| Other non cash items | -74.61M | 96.04M | 126.20M | 203.30M | 51.10M | |||
| OPERATING CASH FLOW | -62.03M | -174.88M | -241.10M | -37.40M | 154.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -286.00K | -2.00M | -1.30M | -7.20M | |||
| Other Investing Activity | 266.09M | 144.93M | -164.80M | -137.10M | -7.20M | |||
| INVESTING CASH FLOW | 266.10M | 144.64M | -166.90M | -138.40M | -14.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 49.90M | -700.00K | 203.60M | |||
| Stock Issued/Repurchased | 3.35M | 74.22M | 9.40M | 54.30M | 21.20M | |||
| Other Financing Activity | 33.25M | -4.62M | -5.00M | -1.80M | -900.00K | |||
| FINANCING CASH FLOW | -186.81M | 69.60M | 54.30M | 51.90M | 223.90M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 17.27M | 39.36M | -353.70M | -123.90M | 363.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -62.03M | -174.88M | -241.10M | -37.40M | 154.10M | |||
| Capital Expenditure | N/A | -286.00K | -2.00M | -1.30M | -7.20M | |||
| FREE CASH FLOW | -62.02M | -175.17M | -243.10M | -38.70M | 146.90M | |||
All data in USD